Comparing different limb lengths in gastric bypass surgery for weight loss
Official title: Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
Run by The Cleveland Clinic · NCT06293703 · Data updated 2026-11-12
This study is testing if adjusting the lengths of parts of gastric bypass surgery can help morbidly obese patients lose more weight and improve health issues like diabetes and high blood pressure compared to standard surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 262 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | January 12, 2024 |
| Main results expected | December 11, 2030 |
| Study ends | December 11, 2030 |
| Registry record updated | March 20, 2026 |
| Trial ID | NCT06293703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are morbidly obese individuals with a BMI between 40 and 60 who are willing to commit to long-term follow-up.
✕Probably not a fit
Patients with a history of previous bariatric surgery, severe unrelated health conditions, or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of limb length ratios in Roux-en-Y gastric bypass surgery on weight loss and metabolic outcomes in morbidly obese patients. Participants will be randomly assigned to receive either standard fixed-length gastric bypass or a ratio-adjusted version that customizes limb lengths based on the patient's total small bowel length. The study aims to determine if the ratio-adjusted approach leads to greater total weight loss and improved resolution of metabolic syndrome comorbidities, such as diabetes and hypertension. Quality of life metrics will also be assessed postoperatively using the SF36 survey.
Why it matters
Potential benefit: If successful, this study could lead to more effective gastric bypass procedures that enhance weight loss and improve metabolic health in morbidly obese patients.
How similar studies have gone: While there have been studies on gastric bypass techniques, this specific approach of using ratio-adjusted limb lengths is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * morbidly obese patients (defined by BMI between 40 and 60). * Patient who understands and accepts the need for a long-term follow-up. * Patient who agrees to be included in the study Exclusion Criteria: * individuals unable to understand and sign a written consent form * patients with history of previous bariatric surgery procedures * presence of a severe and evolutive life threatening pathology unrelated to obesity * previous gastric or small bowel resection * active cancer * pregnancy or desired to be pregnant during the study * mentally unbalanced patients under supervision or guardianship, patient unable to give consent
Where it's running
-
Cleveland clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Salvador Navarrete, MD — The Cleveland Clinic
- Study coordinator: Salvador Navarrete, MD
- Email: navarrs@ccf.org
- Phone: 2162199211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TSBL-based vs BMI-based limb length in one-anastomosis gastric bypass
This trial tests whether calculating the biliopancreatic limb length by total small bowel length (TSBL) helps weight loss and safety more than using standard BMI-based lengths in adults undergoing a single-center OAGB for obesity.
-
Gut stool tests after sleeve vs gastric bypass
This study tests whether routine stool tests can reveal changes in gut function six months after sleeve gastrectomy or gastric bypass in adults with morbid obesity.
-
Impact of Bariatric Surgery on Female Sexual Function and Hormones
This observational study will see how weight loss surgery affects sexual function and hormone levels in women with severe obesity, six months after surgery.
-
Dual-chamber patient-controlled pain relief after laparoscopic sleeve gastrectomy
This test checks whether a dual-chamber IV patient-controlled pump delivering fentanyl plus ketorolac reduces pain and postoperative nausea and vomiting in adults having laparoscopic sleeve gastrectomy.
-
Exercise program to improve weight, strength, and recovery around bariatric surgery
This program will test whether a structured exercise plan supported by telerehabilitation helps adults with severe obesity who are having bariatric surgery lose more body fat and gain more strength than usual care.
-
Comparing rivaroxaban and enoxaparin for preventing blood clots in obese patients undergoing weight loss surgery
This study tests whether the blood thinner rivaroxaban works better than enoxaparin to prevent blood clots in obese patients having weight loss surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.